가톨릭대학교 여의도성모병원은 서울특별시 영등포구 63로 10 에 위치한 병원이다. 과거 명동에 위치했던 성모병원이 영등포구 여의도동으로 옮겨와서 개원한 병원이다.

During the past decade, The Catholic University of Korea, Yeouido St. Mary's Hospital conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 5 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 2 clinical trials were completed. i.e. 6.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Catholic University of Korea, Yeouido St. Mary's Hospital" #1 sponsor was "Seung-Jung Park" with 10 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "The Catholic University of Korea" with 5 trials sponsored, "Boryung Pharmaceutical Co., Ltd" with 3 trials sponsored and "Chong Kun Dang Pharmaceutical" with 3 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Catholic University of Korea, Yeouido St. Mary's Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 13 trials as a collaborator, "Abbott" with 3 trials as a collaborator, "The Catholic University of Korea" with 3 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator and "Academic and Community Cancer Research United" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "The Catholic University of Korea, Yeouido St. Mary's Hospital" are "Coronary Artery Disease" (11 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Breast Cancer" (3 trials), "Depressive Disorder, Major" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "The Catholic University of Korea, Yeouido St. Mary's Hospital" in a lesser frequency.

Most popular intervention types in "The Catholic University of Korea, Yeouido St. Mary's Hospital" are "Drug" (42 trials), "Device" (11 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Atezolizumab" (2 trials), "Aticaprant" (2 trials), "Gemcitabine" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Catholic University of Korea, Yeouido St. Mary's Hospital" are 73 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The Catholic University of Korea, Yeouido St. Mary's Hospital". undefined are not yet recruiting, 18 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in The Catholic University of Korea, Yeouido St. Mary's Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in The Catholic University of Korea, Yeouido St. Mary's Hospital, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 13 trials that are defined as “Not Applicable".